Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models.

Lal, Deepika

Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. [electronic resource] - Molecular cancer therapeutics Oct 2010 - 2737-51 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1538-8514

10.1158/1535-7163.MCT-10-0334 doi


Animals
Anthracyclines--therapeutic use
Antineoplastic Agents--therapeutic use
Female
Humans
Karyotyping
Leukemia, Myeloid, Acute--drug therapy
Mice
Mice, Inbred NOD
Mice, SCID
Receptors, Vascular Endothelial Growth Factor--genetics
Recombinant Fusion Proteins--pharmacology
Transplantation, Heterologous